SP
MR

Sarasin & Partners’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Sarasin & Partners’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-54,917
Closed -$1.66M – 149
2014
Q3 		$1.66M Buy
+54,917
New +$1.7M 0.02% 125

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Sarasin & Partners's MR Position: Q4 2014 in Review

Sarasin & Partners sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q4 2014, closing a stake of 54,917 shares — an estimated $1.66M sold.

Sarasin & Partners first reported a position in MR in Q3 2014 and held it in 1 quarter. The position peaked at $1.66M in Q3 2014. 137 funds tracked by Wall St. Rank hold MR as of Q4 2014.

  • Sarasin & Partners reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q4 2014 after selling out during the quarter.
  • Sarasin & Partners sold 54,917 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q4 2014, an estimated $1.66M.
  • Sarasin & Partners first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q3 2014 and held it in 1 quarter.
  • Sarasin & Partners's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.66M in Q3 2014.
  • 137 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q4 2014.

Based on Sarasin & Partners's 13F filing for Q4 2014, filed 26 Jan 2015.